Skip to content

MyCare Psychiatry Olanzapine Assay Kit

by Saladax Biomedical Inc.

Ref OLZ-RGT

Active European Union

CE IVDD

Valid until

Not listed

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 24 Oct 2026. What this means

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-00894354002267 Basic UDI-DI 00894354002267UDI-DIDate16 Oct 2026RegisteredStatusActive

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDD Active

Specification

EUDAMED

Model / Reference
OLZ-RGT
Primary DI / UDI-DI
00894354002267
Basic UDI-DI
B-00894354002267
EMDN Code
W01020899 Therapeutic drug monitoring - other
Device Class
Class IVD General
EU market of registration
France

Manufacturer details

EUDAMED SRN
US-MF-000007957
Authorised representative
Emergo Europe B.V. NL-AR-000000116

Other devices from Saladax Biomedical Inc.

See all devices from Saladax Biomedical Inc. →

Properties

  • Reagent
  • Professional Testing

Other properties (8)

  • Sterile: No
  • Human Tissues: No
  • Animal Tissues: No
  • Microbial Substances: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No